medications

Stock Market

Novavax stock shedding a quarter of its value as vaccine maker’s business in ‘substantial doubt’

[ad_1] Novavax Inc. shares shares sank in the extended session Tuesday after the biotech drug maker posted more than double…

Read More »
Stock Market

Novavax: ‘Substantial Doubt’ Around Ability to Continue

[ad_1] Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this…

Read More »
Stock Market

Moderna Earnings Hit by Falling Covid Vaccine Sales

[ad_1] Moderna stock fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings…

Read More »
Stock Market

Bulls may be losing enthusiasm for stocks, but these 3 potential takeover plays could land in the money

[ad_1] The U.S. stock market, as measured by the S&P 500 Index SPX, -0.72%, had finally broken out over triple…

Read More »
Stock Market

Robinhood accidentally sold short on a meme stock and lost $57 million

[ad_1] Robinhood Markets Inc. accidentally sold short on a small stock as it went on a meme-like ride in December,…

Read More »
Stock Market

Catalent Stock Surges on Report of Danaher Interest

[ad_1] Catalent stock surged nearly 25% in premarket trading Monday following a report that life sciences company Danaher has expressed…

Read More »
Stock Market

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

[ad_1] Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped…

Read More »
Dallas

Walgreens, CVS Limit Sales of Children’s Medications Amid ‘Tripledemic’

[ad_1] CVS and Walgreens are limiting how many children’s pain relief medications people can buy at once amid a winter “tripledemic”…

Read More »
Stock Market

Moderna Stock Is Upgraded on Growth Opportunities Not Related to Covid

[ad_1] Moderna was rising Monday after an analyst at Jefferies upgraded the stock citing confidence in the vaccine maker’s growth…

Read More »
Stock Market

BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline

[ad_1] Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA…

Read More »
Back to top button
Close